Top Navigation

Health Equity and Cultural Diversity

Our Mission:

To advance the knowledge and practice of psychosocial cancer care for all members of society by eliminating barriers to inclusion and alleviating disparities.

2019 Goals:

Building on the momentum from last year, to continue to increase SIG activity and membership, and determine priorities and next steps in collaboration with SIG members.

Overall Goals:

  • To foster awareness of health disparities in cancer, enhancing culturally and socio-ecologically responsive prevention/early detection/quality of life/psychosocial care, and promoting diversity inclusion in our field.
  • To promote research, and clinical and supportive care to identify cancer disparities and promote optimal health related quality of life and survivorship outcomes for all.
  • To develop and evaluate community‐based, culturally informed and clinically‐responsive research methods to enhance recruitment and retention of underserved and ethnic minority cancer populations in behavioral research trials.

All APOS members are welcome to participate!

Listserv: (please subscribe by emailing the listserv with SUBSCRIBE in the subject line) 

Meet the Chairs: 

Charles Kamen, PhD, MPH, is an Assistant Professor at the University of Rochester and serves as the Chair of Health Equity Research for the University of Rochester NCI Community Oncology Research Program (NCORP) Research Base.  He is a licensed clinical psychologist and holds a PhD from the University of Georgia and an MPH from the University of Rochester.  Dr. Kamen’s research focuses on cancer-related health disparities affecting sexual and gender minority (e.g., lesbian, gay, bisexual, transgender) cancer patients and survivors. He has developed tailored interventions for SGM cancer patients and their caregivers, and has worked with community organizations to develop best practices for improving cancer care delivery to SGM patients and to collect sexual orientation and gender identity data in the context of cancer care.  Dr. Kamen’s research has been funded by the National Cancer Institute and the Gay and Lesbian Medical Association’s Lesbian Health Fund.